---
figid: PMC9353634__br-17-03-01560-g02
pmcid: PMC9353634
image_filename: br-17-03-01560-g02.jpg
figure_link: /pmc/articles/PMC9353634/figure/f3-BR-17-3-01560/
number: Figure 3
figure_title: ''
caption: ET-1 and eNOS mRNA levels following treatment with cilostazol. (A) ET-1 mRNA
  levels following pre-incubation with/without the p38 inhibitor (SB203580). (B) mRNA
  levels following pre-incubation with/without p38 inhibitor (SB203580). *P<0.05,
  **P<0.01. ET-1, endothelin-1; eNOS, endothelial nitric oxide synthase; ns, not significant.
article_title: Cilostazol regulates the expressions of endothelin-1 and endothelial
  nitric oxide synthase via activation of the p38 MAPK signaling pathway in HUVECs.
citation: Ying Xue, et al. Biomed Rep. 2022 Sep;17(3):77.
year: '2022'

doi: 10.3892/br.2022.1560
journal_title: Biomedical Reports
journal_nlm_ta: Biomed Rep
publisher_name: D.A. Spandidos

keywords:
- cilostazol
- endothelial dysfunction
- endothelin-1
- endothelial nitric oxide synthase
- p38 MAPK

---
